In contrast, the activity of tumor-infiltrating CD4+ and CD8+ T cells was significantly enhanced by cisplatin, as evaluated by their ability to secrete cytokines, e.g., INF-γ and TNF-α (Fig. 8F–I). The gene discussed is CD8A; the disease is neoplasm.